A pragmatic approach to dealing with fingolimod-related lymphopaenia in Europe

Research output: Contribution to journal › Research article › Contributed › peer-review

Contributors

  • Gavin Giovannoni - , Queen Mary University of London (Author)
  • Brigit de Jong - , Radboud University Medical Center (Author)
  • Tobias Derfuss - , University Hospital Basel (Author)
  • Guillermo Izquierdo - , Hospital Universitario Virgen Macarena (Author)
  • Gordon Mazibrada - , University Hospitals Birmingham NHS Foundation Trust (Author)
  • Paul Molyneux - , Cambridge University Hospitals NHS Foundation Trust (Author)
  • Richard Nicholas - , Charing Cross Hospital (Author)
  • James Overell - , NHS Greater Glasgow and Clyde (Author)
  • Tjalf Ziemssen - , Department of Neurology, Center of Clinical Neuroscience, Neurological University Clinic Dresden, TUD Dresden University of Technology, Structure and Materials Mechanics Research Institute at the Dresden University of Technology (SWM) (Author)
  • Gunnar Juliusson - , Lund University (Author)

Details

Original languageEnglish
Pages (from-to)83-4
Number of pages2
JournalMultiple sclerosis and related disorders
Volume4
Issue number1
Publication statusPublished - Jan 2015
Peer-reviewedYes

External IDs

Scopus 84920625413

Keywords

Keywords

  • Europe, Fingolimod Hydrochloride/adverse effects, Humans, Immunosuppressive Agents/adverse effects, Lymphopenia/chemically induced, Multiple Sclerosis/drug therapy